1. Home
  2. UNM vs BMRN Comparison

UNM vs BMRN Comparison

Compare UNM & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unum Group

UNM

Unum Group

HOLD

Current Price

$75.29

Market Cap

12.0B

Sector

Finance

ML Signal

HOLD

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

HOLD

Current Price

$55.74

Market Cap

10.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UNM
BMRN
Founded
1848
1996
Country
United States
United States
Employees
10910
N/A
Industry
Accident &Health Insurance
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.0B
10.0B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
UNM
BMRN
Price
$75.29
$55.74
Analyst Decision
Buy
Buy
Analyst Count
11
17
Target Price
$94.27
$87.24
AVG Volume (30 Days)
1.4M
1.9M
Earning Date
01-01-0001
05-21-2026
Dividend Yield
2.48%
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.80
Revenue
N/A
$1,313,646,000.00
Revenue This Year
N/A
$13.34
Revenue Next Year
$4.84
$11.42
P/E Ratio
$17.16
$32.34
Revenue Growth
N/A
17.62
52 Week Low
$66.81
$50.76
52 Week High
$84.48
$73.18

Technical Indicators

Market Signals
Indicator
UNM
BMRN
Relative Strength Index (RSI) 57.56 34.51
Support Level $72.54 $52.30
Resistance Level $79.92 $56.89
Average True Range (ATR) 2.17 2.08
MACD 0.31 -0.64
Stochastic Oscillator 97.74 4.37

Price Performance

Historical Comparison
UNM
BMRN

About UNM Unum Group

Unum Group is a provider of group and individual income protection insurance products in the United States, the United Kingdom, Poland, and other countries. It is the domestic disability insurer, with the majority of premiums generated from employer plans. The company also offers a complementary portfolio of other insurance products, including long-term care insurance, life insurance, and employer- and employee-paid group benefits. It has the following operating business segments: Unum USA, Unum International, Closed Block, Colonial Life, and Corporate. The Unum USA segment generates the majority of revenue. The firm markets its products through brokers.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Share on Social Networks: